Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$977K Buy
35,433
+6,615
+23% +$146K ﹤0.01% 1493
2026
Q1
$421K Sell
28,818
-164,507
-85% -$2.41M ﹤0.01% 1587
2025
Q4
$2.44M Buy
193,325
+158,395
+453% +$2.34M ﹤0.01% 998
2025
Q3
$537K Buy
34,930
+4,843
+16% +$78.1K ﹤0.01% 1473
2025
Q2
$473K Sell
30,087
-475,658
-94% -$7.21M ﹤0.01% 1477
2025
Q1
$9.66M Sell
505,745
-825
-0.2% -$18.1K 0.02% 646
2024
Q4
$12.1M Buy
506,570
+77,582
+18% +$2.17M 0.02% 594
2024
Q3
$12M Buy
428,988
+65,477
+18% +$1.85M 0.02% 610
2024
Q2
$9.51M Buy
363,511
+242,388
+200% +$5.04M 0.02% 622
2024
Q1
$2.65M Buy
121,123
+87,349
+259% +$1.87M 0.01% 953
2023
Q4
$785K Buy
33,774
+11,681
+53% +$235K ﹤0.01% 1279
2023
Q3
$436K Sell
22,093
-5,889
-21% -$116K ﹤0.01% 1380
2023
Q2
$634K Buy
27,982
+9,004
+47% +$181K ﹤0.01% 1275
2023
Q1
$373K Buy
+18,978
New +$364K ﹤0.01% 1377

Other funds holding RXO

Natixis Advisors's RXO Position: Q2 2026 in Review

Natixis Advisors increased its RXO (RXO) stake by 23% in Q2 2026, buying an estimated $146K and bringing the position to 35,433 shares worth $977K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Natixis Advisors first reported a position in RXO in Q1 2023 and has held it in 14 quarters since. The position peaked at $12.1M in Q4 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Natixis Advisors held 35,433 shares of RXO worth $977K as of Q2 2026.
  • Natixis Advisors bought 6,615 RXO shares in Q2 2026, an estimated $146K.
  • RXO made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1493 holding.
  • Natixis Advisors first reported a position in RXO in Q1 2023 and has held it in 14 quarters since.
  • Natixis Advisors's RXO position peaked at $12.1M in Q4 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.